| 4IV1 | date | ![]() |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||||||
| compound | source | ||||||||||||||||||
| symmetry |
| ||||||||||||||||||
| crystal cell |
| ||||||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||||||
| Gene Ontology |
| ||||||||||||||||||
| Primary reference | Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen., Porta C, Kotecha A, Burman A, Jackson T, Ren J, Loureiro S, Jones IM, Fry EE, Stuart DI, Charleston B, PLoS Pathog. 2013 Mar;9(3):e1003255. doi: 10.1371/journal.ppat.1003255. Epub 2013, Mar 27. PMID:23544011 | ||||||||||||||||||
| Data retrieval |
![]() |
| View 4IV1 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |